CompaniesNantPharma

NantPharma

defunct
About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (3)
View all

Total Trials

3

As Lead Sponsor

3

As Collaborator

0

Total Enrollment

8

By Phase

PHASE2: 2PHASE1/PHASE2: 1

By Status

WITHDRAWN: 2TERMINATED: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2017
2018
2019
2020
2021
2022
2023
2024
Today
NCT03127124
NCT03147976
NCT03132155
Hover over trial bars to see details

Recent Trials

NCT03132155Lead Sponsor
QUILT-3.031: AMG 337 in Subjects With Advanced or Metastatic Clear Cell Sarcoma
PHASE2Terminated
8 participants
Started: Aug 29, 2018 · Completed: Sep 21, 2021
NCT03147976Lead Sponsor
QUILT-3.036: AMG 337 in Subjects With Advanced or Metastatic Solid Tumors
PHASE2Withdrawn
Started: May 2, 2018 · Completed: Aug 23, 2019
NCT03127124Lead Sponsor
QUILT-2.022 NANT-008 in Combination w/ 5-fluorouracil, Bevacizumab, Leucovorin & Oxaliplatin in Subjects With Pancreatic Cancer
PHASE1/PHASE2Withdrawn
Started: Feb 27, 2018 · Completed: Dec 6, 2023